IP Verse

5-Methoxy-N,N-Dimethyltryptamine (5-Meo-Dmt) For Treating Depression

Patent No. EP3927337 (titled "5-Methoxy-N,N-Dimethyltryptamine (5-Meo-Dmt) For Treating Depression") was filed by GH Research on Feb 24, 2020. The application was issued on Mar 20, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
STRAWMANNov 13, 2024CMS CAMERON MCKENNA NABARRO OLSWANG
PORTA SOPHIAMay 22, 2024FLEUCHAUS & GALLO PARTNERSCHAFT MBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3927337

GH RESEARCH
Application Number
EP20710059A
Filing Date
Feb 24, 2020
Status
Granted And Under Opposition
Jan 12, 2024
Publication Date
Mar 20, 2024
External Links
Slate, Register , Google Patents